2.15% 0.0587

Windtree Therapeutics Inc (WINT)

Windtree Therapeutics Inc 주식(WINT)의 최신 뉴스

Windtree Therapeutics Inc (WINT)

Windtree Therapeutics Inc 주식(WINT)의 최신 뉴스

Understanding WINT stock ratios for better investment decisions - US Post News

WINT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

In the Green: Windtree Therapeutics Inc (WINT) Closes at 3.45, Up/Down 23.21 from Previous Day - The Dwinnex

Windtree Therapeutics Advances Heart Failure Treatment with SEISMiC Extension Study Completion - MSN

Windtree Therapeutics Advances Heart Failure Treatment with SEISMiC Extension Study Completion - MyChesCo

Take off with Windtree Therapeutics Inc (WINT): Get ready for trading - SETE News

WINT stock touches 52-week low at $2.8 amid sharp annual decline - Investing.com

WINT stock touches 52-week low at $2.8 amid sharp annual decline - Investing.com Canada

Market Insights: Windtree Therapeutics Inc (WINT)’s Notable Gain of 4.08, Closing at 3.32 - The Dwinnex

Windtree Therapeutics Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

What's Going On With Windtree Therapeutics Stock Wednesday? - Benzinga

Windtree (WINT) Stock Climbs In Pre-Market Trading After Major Update - Stocks Telegraph

Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock - GlobeNewswire

Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock - StockTitan

When the Price of (WINT) Talks, People Listen - Stock Traders Daily

Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Down 56.8% in August - Defense World

Analyzing Windtree Therapeutics (NASDAQ:WINT) & ZIVO Bioscience (NASDAQ:ZIVO) - Defense World

Windtree Therapeutics Reports Second-Quarter Financial Results and Key Business Updates - MSN

Windtree Therapeutics Reports Second-Quarter Financial Results and Key Business Updates - MyChesCo

Windtree Therapeutics (NASDAQ:WINT) Issues Quarterly Earnings Results, Misses Expectations By $12.80 EPS - Defense World

Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates - GlobeNewswire

Windtree Therapeutics reports Q2 EPS ($20.91) vs. ($29.47) last year - TipRanks

WINT Stock Earnings: Windtree Therapeutics Reported Results for Q1 2024 - InvestorPlace

Sorrento Therapeutics (OTC:SRNE) Stock Quotes, Forecast and News Summary - Benzinga

Windtree Therapeutics Announces New Board Appointments - MyChesCo

Windtree Therapeutics announces board changes - Investing.com India

Windtree Announces New Additions and Changes to Its Board of Directors - GlobeNewswire

Windtree Therapeutics reshapes board with new directors - Investing.com India

Windtree Therapeutics announces board changes By Investing.com - Investing.com Canada

Windtree Therapeutics announces board changes - Investing.com

Windtree Therapeutics announces board changes By Investing.com - Investing.com Australia

Windtree Therapeutics announces board changes By Investing.com - Investing.com UK

Windtree Therapeutics reshapes board with new directors - Investing.com

Windtree Therapeutics Board Reshuffles, Appoints New Directors - TipRanks

Windtree Announces New Additions and Changes to Its Board of Directors - StockTitan

Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Grows By 455.6% - Defense World

What's Going On With Windtree Therapeutics Stock? - MSN

Trading Day Review: Windtree Therapeutics Inc (WINT) Gains Momentum, Closing at 9.12 - The Dwinnex

Why Windtree Therapeutics (WINT) Stock Is Volatile Today - MSN

Windtree Therapeutics Inc: Analyzing WINT Stock Trends - The InvestChronicle

Windtree secures $1M in private placement deal By Investing.com - Investing.com Canada

Windtree secures $1M in private placement deal - Investing.com

Windtree secures $1M in private placement deal By Investing.com - Investing.com Nigeria

Windtree secures $1M in private placement deal - Investing.com India

Why Windtree Therapeutics (WINT) Stock Is Volatile Today - Benzinga

A closer look at Windtree Therapeutics Inc’s (WINT) current quarter earnings projections - US Post News

Holdings of Windtree Therapeutics Inc (WINT) are aligned with the stars - SETE News

Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Decreases By 17.5% - Defense World

Windtree Therapeutics (WINT) Advancing Cardiac Innovation with Istaroxime - BP Journal

Windtree Therapeutics Advances Heart Failure Treatment in New Clinical Trials - MyChesCo

Should investors be concerned about WINT’s high price-to-sales ratio? - US Post News

Why Is BurgerFi International (BFI) Stock Up 71% Today? - InvestorPlace

Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results - Benzinga

Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5% - Benzinga

Windtree Therapeutics provides update on istaroxime development - TipRanks

Windtree Therapeutics Inc (WINT) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

What's Going On With Windtree Therapeutics Stock? - Benzinga

Why Is Windtree Therapeutics (WINT) Stock Up 116% Today? - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace

Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga

Philly daily roundup: A serial founder's new venture; Behind the UArts closure; Windtree Therapeutics raises $12.9M - Technical.ly

WINT과 유사한 종목